Michael Ihnat to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications Michael Ihnat has written about Xenograft Model Antitumor Assays.
Connection Strength
0.305
-
Identification of novel drugs to target dormant micrometastases. BMC Cancer. 2015 May 14; 15:404.
Score: 0.115
-
A small molecule with anticancer and antimetastatic activities induces rapid mitochondrial-associated necrosis in breast cancer. J Pharmacol Exp Ther. 2015 May; 353(2):392-404.
Score: 0.113
-
Synthesis and evaluation of 5-(arylthio)-9H-pyrimido[4,5-b]indole-2,4-diamines as receptor tyrosine kinase and thymidylate synthase inhibitors and as antitumor agents. Bioorg Med Chem Lett. 2017 04 01; 27(7):1602-1607.
Score: 0.032
-
Solid phase synthesis and biological evaluation of probestin as an angiogenesis inhibitor. Bioorg Med Chem Lett. 2013 Jun 15; 23(12):3561-4.
Score: 0.025
-
Novel STAT3 phosphorylation inhibitors exhibit potent growth-suppressive activity in pancreatic and breast cancer cells. Cancer Res. 2010 Mar 15; 70(6):2445-54.
Score: 0.020